18,820 Oscar Health, Inc. $OSCR Shares Sold by State of Wyoming

State of Wyoming lessened its stake in Oscar Health, Inc. (NYSE:OSCR) by 57.3% during the 3rd quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 14,018 shares of the company’s stock after selling 18,820 shares during the period. State of Wyoming’s holdings in Oscar Health were worth $432,000 at the end of the most recent quarter.

A number of other hedge funds and other institutional investors have also made changes to their positions in OSCR. Bank of America Corp DE lifted its stake in shares of Oscar Health by 205.1% in the 1st quarter. Bank of America Corp DE now owns 2,860,310 shares of the company’s stock valued at $32,808,000 after purchasing an additional 1,922,732 shares during the period. Assenagon Asset Management S.A. boosted its holdings in Oscar Health by 107.5% during the third quarter. Assenagon Asset Management S.A. now owns 2,589,708 shares of the company’s stock worth $79,867,000 after buying an additional 1,341,716 shares in the last quarter. Wedge Capital Management L L P NC acquired a new stake in Oscar Health during the second quarter valued at $32,855,000. Dimensional Fund Advisors LP grew its position in Oscar Health by 22.1% during the first quarter. Dimensional Fund Advisors LP now owns 4,192,777 shares of the company’s stock valued at $48,078,000 after buying an additional 759,837 shares during the period. Finally, Halter Ferguson Financial Inc. increased its holdings in Oscar Health by 93.3% in the third quarter. Halter Ferguson Financial Inc. now owns 1,211,825 shares of the company’s stock valued at $37,373,000 after buying an additional 584,818 shares in the last quarter. Institutional investors and hedge funds own 75.70% of the company’s stock.

Oscar Health Price Performance

Shares of NYSE OSCR opened at $32.38 on Wednesday. The firm has a market cap of $9.99 billion, a PE ratio of 23.13, a PEG ratio of 0.34 and a beta of 2.56. The firm has a fifty day moving average of $31.68 and a 200 day moving average of $23.72. The company has a debt-to-equity ratio of 0.21, a quick ratio of 1.09 and a current ratio of 1.09. Oscar Health, Inc. has a one year low of $10.69 and a one year high of $35.01.

Oscar Health (NYSE:OSCR) last posted its quarterly earnings data on Thursday, August 6th. The company reported $1.10 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.40 by $0.70. Oscar Health had a net margin of 3.60% and a return on equity of 38.45%. The business had revenue of $4.88 billion for the quarter, compared to the consensus estimate of $4.73 billion. During the same period last year, the firm posted ($0.89) earnings per share. The company’s revenue was up 70.4% compared to the same quarter last year. As a group, research analysts predict that Oscar Health, Inc. will post 1.83 EPS for the current fiscal year.

Insider Activity

In related news, Director Mario Schlosser sold 600,000 shares of Oscar Health stock in a transaction dated Thursday, August 27th. The stock was sold at an average price of $30.34, for a total value of $18,204,000.00. Following the sale, the director directly owned 480,866 shares in the company, valued at approximately $14,589,474.44. The trade was a 55.51% decrease in their position. The transaction was disclosed in a filing with the SEC, which is accessible through this hyperlink. Also, insider Janet Liang sold 10,360 shares of the business’s stock in a transaction that occurred on Thursday, September 3rd. The stock was sold at an average price of $31.45, for a total value of $325,822.00. Following the sale, the insider owned 248,697 shares of the company’s stock, valued at approximately $7,821,520.65. This trade represents a 4.00% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Over the last 90 days, insiders have sold 874,451 shares of company stock worth $26,761,671. Company insiders own 22.64% of the company’s stock.

Analyst Ratings Changes

OSCR has been the subject of a number of analyst reports. Barclays upped their price objective on shares of Oscar Health from $39.00 to $49.00 and gave the stock an “overweight” rating in a research report on Thursday, September 17th. Weiss Ratings upgraded Oscar Health from a “hold (c+)” rating to a “buy (b-)” rating in a research report on Thursday, October 8th. Robert W. Baird lifted their price target on Oscar Health from $27.00 to $33.00 and gave the company a “neutral” rating in a research note on Thursday, September 17th. Bank of America upped their price target on Oscar Health from $28.00 to $30.00 and gave the stock an “underperform” rating in a report on Thursday, September 17th. Finally, Wells Fargo & Company increased their price target on Oscar Health from $20.00 to $27.00 and gave the stock an “equal weight” rating in a research report on Thursday, August 13th. One analyst has rated the stock with a Strong Buy rating, four have assigned a Buy rating, seven have given a Hold rating and one has issued a Sell rating to the company’s stock. According to data from MarketBeat, the stock presently has a consensus rating of “Hold” and an average target price of $34.90.

Oscar Health Profile

Oscar Health, Inc is a technology-focused health insurance company that provides health plans and related services in the United States. The company primarily serves individuals and families purchasing coverage through the Affordable Care Act’s health insurance marketplace, as well as small businesses and their employees.

Oscar combines health insurance products with digital tools designed to help members manage their care. Its services include online enrollment, virtual care, provider search and appointment support, care navigation, claims and benefits information, and member engagement through web and mobile applications.